Abstract
Introduction
The role of matrix metalloproteases (MMPs) in remodelling the extracellular matrix and inducing cell migration in both physiological and pathological conditions has been reviewed extensively [1, 2] . In particular, the increased expression and activity of gelatinases MMP-2 and MMP-9 have been demonstrated to contribute to the pathogenesis of several inflammatory diseases and tumours [1, [3] [4] [5] Besides the well-known proteolytic degradation of type IV collagen, MMPs might induce the migration of inflammatory and tumour cells by forming new capillary vessels, concurring in the development of pathological angiogenesis [1, 2, 6] . Of interest is the finding that growth factors and cytokines that stimulate the expression and cellular secretion of heat-shock proteins (HSPs) also stimulate the expression of MMPs, thus enhancing the inflammatory response and promoting its spreading by autocrine-paracrine mechanisms [7] [8] [9] .
We recently demonstrated that in the plasma of type 1 diabetic subjects the antibody fraction that was stably complexed with the glucose-regulated protein94 (Grp94) stimulated the angiogenic differentiation of human umbilical vein endothelial cells (HUVECs) by a mechanism that involved the increased expression of both HSP90 and HSP70, the latter resulting closely associated with a cell membrane-bound inactive species of MMP-9 [10] . Our results supported the conclusion that circulating Grp94-IgG complexes might be a marker of an increased angiogenic risk sustained by HSP-chaperoned, proteolytically inactive forms of MMP-9. This
Grp94-IgG complex
The Grp94-IgG complex was obtained by incubating native Grp94, purified from rat liver microsomal fractions, with human, pre-immmune IgG at the molar ratio of 1:1 for 1 hr at 37ЊC, and its formation tested as previously specified [11] . The Grp94-IgG complex was used in experiments of cell cultures at the final concentration of 10 ng/ml, because in previous experiments this was proven to be effective in supporting the proliferation and angiogenic transformation of HUVECs [11] .
Cell cultures
HUVECs were isolated from freshly collected umbilical veins by collagenase treatment [16] . At least three different fresh cords were employed for any cell preparation. Cells were maintained in EBM supplemented with 10% (v/v) FBS, 100 units/ml penicillin, 10 g/ml streptomycin, 20 g/ml endothelial cell growth supplement at 37ЊC in a humidified 95% air, 5% CO2 atmosphere, until the cells reached sub-confluence. Cell 
culture purity was assessed by microscopic examination of the typical cobblestone morphology and by phycoerythrin (PE) mouse anti-human CD31 monoclonal Abs (BD Pharmingen™, San Josè, CA, USA). All experiments were performed with HUVECs at passages 3-5.

Cell proliferation assays
The MEK-ERK1/2 pathway is dispensable for the angiogenic-like effect of the Grp94-IgG complex
We previously demonstrated that both the stimulation of endothelial cell proliferation and induction of differentiation by Grp94-IgG were 
mediated by an intense activation of the MEK-ERK1/2 pathway, even higher than that observed with native Grp94 alone [11]. An intense and prolonged activation of ERK1/2 is recognized to underlie the differentiation of HUVECs into tubule-like formations [17, 18]. Because CTT on its own was apparently as active as Grp94-IgG in inducing the differentiation process of endothelial cells, it was of interest to see whether MEK-ERK1/2 pathway was further stimulated by the addition of CTT. After 18 hrs incubation, an intense phosphorylation of ERK1/2 was observed with Grp94-IgG (Fig. 2A), further stimulated by pre-treatment with CTT, irrespective of the concentration, a finding that supported the permissive effect of CTT on the induction of angiogenic-like transformation of HUVECs. The same result however excluded that the MEK-ERK1/2 pathway was directly involved in mediating the inhibition of cell proliferation by CTT. Because CTT alone did not affect at all the phosphorylation of ERK1/2 (the signal was even lower than that of control) (Fig. 2A), the effect of enhancement of ERK1/2 phosphorylation by CTT could be explained by invoking an indirect mechanism of activation by CTT on a pathway, also targeted by Grp94-IgG, other than the MEK-ERK1/2 one. That the differentiation effect of Grp94-IgG on HUVECs was independent of the MEK/ERK1/2 pathway was confirmed by experiments in which cells were treated with the MEK-ERK1/2 inhibitor U0126 (10 M, final concentration) before the addition of both Grp94-IgG and CTT. Although U0126 markedly reduced the ERK1/2 phosphorylation in both control and Grp94-IgG-treated cells, with or without CTT, it nevertheless left unchanged the effect of Grp94-IgG on cell differentiation, both in absence and presence of CTT, (data not shown), i.e. cell morphology was similar to that observed in absence of U0126. This finding further corroborated the idea that Grp94-IgG sustains the angiogenic-like transformation of HUVECs mainly targeting cellular pathways other than the MEK-ERK1/2 that might be involved secondarily through the cross-talk with closely associated pathways(s) eventually leading to the intense downstream activation of P-ERK1/2 [11].
The PI3K/Akt pathway mediates the angiogeniclike effect of the Grp94-IgG complex
The possibility was then considered that the PI3K/Akt pathway could mediate effects of Grp94-IgG on HUVECs, because this pathway plays a pivotal role in the process of endothelial cell proliferation and differentiation [19] . Both total and phosphorylated forms of Akt of cell lysates were intensely stimulated by Grp94-IgG after 18 hrs incubation (Fig. 2B) [21] . Results of our previous work supported the proposal that the angiogenic effect of Grp94-IgG is (Fig. 3, panels b) , to testify the intense cytoskeleton modification accompanying proliferation and angiogenic transformation of cells. CTT at 10 M led to a significant reduction in both the podosomes number and HSP90-dependent fluorescence sustained by Grp94-IgG, although it did not antagonize completely this effect, and HSP90 expression appeared to be still increased with respect to the control (Fig. 3,  panels (Fig. 3, panels c) 
HSP90 is involved in the activation of the PI3K/Akt pathway by both Grp94-IgG and CTT
It has been reported that intracellular Akt is a client protein of HSP90 that forms complexes in which Akt is stabilized and rendered functionally active
d). CTT alone was as effective as Grp94-IgG in stimulating the podosome formation and in inducing the expression of HSP90
CTT does not counteract the effects of Grp94-IgG on the MMP-9 expression and secretion
It has firmly been established that mitogenic stimuli that promote cell proliferation and differentiation also lead to an increased expression of MMP-9 [23] , and that MMP-9 expressed by endothelial cells is critical for inducing angiogenesis [6, 12] . However, mechanisms by which MMP-9 might contribute to the development and progression of angiogenesis are still controversial, although it appears to be for most part independent of MMP-9 proteolytic activity [10, 11, 24] [12] , the role of activated PI3K/Akt pathway in driving stimulation of MMP-9 production and secretion [8, 25] has been considered with much higher relevance.
. Despite the intensive effort spent in this direction, the signal transduction pathway(s) specifically involved in regulating the expression of MMP-9 following application of various stimuli has not been identified with precision. While the phosphorylation of ERK1/2 appears to be not sufficient for the expression of MMP-9
In immunoblotting experiments with monoclonal anti-MMP-9 Abs
Fig. 4 CTT enhances the Grp94-IgG complex-induced increase in HSP90 secretion from HUVECs. Cells (25 ϫ 10 4 ) were cultured as specified in 'Materials and methods' and after a 18 hrs incubation in absence (control) and presence of Grp94-IgG complexes (10 ng/ml) and CTT (10 M), both alone and together, cells were lysed and Western blotting for HSP90 performed on both the membrane fraction (native lysates) (A) and on whole cell lysates (B). The same quantity of proteins was loaded in each lane without the addition of ␤-mercaptoethanol. (C) Media were collected from cultured cells before cell lysis (as specified above), lyophilized and re-suspended in sample buffer (without the addition of ␤-mercaptoethanol) for being analysed in Western blotting with anti-HSP90␣/␤ Abs. Fifteen microlitres were loaded in each lane. A representative Western blotting of four independent analyses is presented in (A), (B) and (C). Below each blotting is the graph with histograms representing the mean (ϮS.D.) of densitometric analysis of the bands measured in all experiments (n ϭ 4). on whole lysates of HUVECs treated with Grp94-IgG, with and without CTT, we were unable to measure the expression of MMP-9, whereas the inactive (94 kD) form of MMP-9 was detected in gel zymography experiments on culture media, to testify active secretion. Much less intense and of variable intensity was the digestion band referred to the active form of MMP-9 at 92 kD. The MMP-9 pro-form underwent an intense stimulation with both Grp94-IgG and CTT alone (Fig. 5). Again, when tested together, CTT did not reverse at all the stimulation sustained by Grp94-IgG, causing instead a further increase in the area of the digestion band of MMP-9 pro-form that is activated experimentally by zymography. The results are in accord with those reported above, supporting the possibility that the synergic stimulation of the PI3K/Akt pathway by Grp94-IgG and CTT can also mediate the increase in MMP-9 pro-form expression and secretion.
The HSP90 inhibitor PU-H71 inhibits the stimulation of both HSP90 expression and Akt activity induced by Grp94-IgG 
6B). It is worth noting that the same effect was also present with PU-H71 alone, as if the inhibition of HSP90 as such could lead to the block of HSP90 secretion. PU-H71 at its lower concentration did not reduce significantly the Akt expression in cell lysates treated with Grp94-IgG (data not shown), whereas markedly inhibited Akt and P-Akt at 150 nM (Fig. 7). No substantial modification in the Akt activity was instead noted with PU-H71 alone. Results suggest that PU-H71 can antagonize the effects induced by Grp94-IgG on cellular HSP90, mostly affecting the delivery to cell membrane and secretion of HSP90 from the cell. This would imply interference with mechanisms of autocrine-paracrine activation of cell proliferation and angiogenic differentiation promoted by HSP90.
PU-H71 inhibits the MMP-9 pro-form expression and the angiogenic-like transformation of HUVECs induced by Grp94-IgG
The effective inhibition by PU-H71 of the HSP90 expression and secretion stimulated by Grp94-IgG would predict antagonism on the angiogenic-like promoting activity of Grp94-IgG. In addition, because MMP-9 is actively involved in the angiogenic process, and its stimulation by Grp94-IgG is mediated by HSP90-dependent Akt activation, it would be expected that the expression of MMP-9 were similarly inhibited by PU-H71. Experiments of zymography showed that PU-H71 at the highest concentration caused a significant reduction in the secretion of MMP-9 pro-form stimulated by Grp94-IgG (Fig. 8). This result indirectly proved that the Akt pathway was involved in the process of MMP-9 transport to the membrane and secretion from the cell that is functional to the diffusion of angiogenesis.
Optical microscopy inspection also revealed that PU-H71 was able to restore, in a concentration-dependent manner, the normal morphology of HUVECs, the tubule-like formations induced by Grp94-IgG being completely antagonized at 150 nM PU-H71 (Fig. 9) . HUVECs were mediated by an increase in the expression and activity of MMP-9 [11] , and MMPs are known to play a crucial role in sustaining angiogenesis and endothelial cell migration in pathological conditions [2, 6] . Grp94-IgG complexes isolated from plasma of diabetic subjects were identified as a marker of increased risk for developing vascular alterations that in time lead to stable and severe complications characterizing diabetes [10] . Thus, because CTT was proven effective in blocking angiogenesis and invasion of the blood vessel wall in tumour cells, thanks to specific anti-gelatinase activity [6, 13] , morphological alterations induced by Grp94-IgG on endothelial cells might also be expected to be inhibited by CTT, thus supporting the use of CTT as antiangiogenic agent also in conditions characterized by an increased concentration of these circulating complexes [10] .
Fig. 5 CTT does not antagonize the Grp94-IgG complex-dependent increase in the MMP-9 secretion. Media collected from cultured cells in absence (control) and presence of Grp94-IgG complexes (10 ng/ml) and CTT, both alone and together, were analysed in gel zymography for gelatinase activity, as specified in 'Materials and methods'. A representative gel zymography of ten independent experiments is reported, showing the digestion band referred to the inactive, 94 kD MMP-9 pro-form, activated experimentally by zymography. Fifteen microlitres were loaded in each lane. Below is the graph with histograms representing the mean (ϮS.D.) of the optical density (in arbitrary units) of the bands measured in all experiments (n ϭ 10).
Discussion
In this work we tested the selective MMP-2 and MMP-9 inhibitor, the cyclic decapeptide CTT as a potential inhibitor of proliferation and angiogenic-like transformation of HUVECs induced by complexes of Grp94-IgG. The choice of CTT was dictated by the previous observations showing that effects of complexes Grp94-IgG on
Results allowed us to address in depth the still unmet question of the molecular pathway specifically targeted by Grp94-IgG complexes for inducing morphological alterations in endothelial cells [11] . At the same time, we faced unexpected paradoxical biological effects of CTT. In particular, not only was CTT unable to inhibit angiogenic-like effects on HUVECs, but it even displayed a dose dependent, pronounced capacity to induce angiogenic transformation of cells (Fig. 1) [28] . Importantly also, these unexpected, unwanted effects appeared to be independent of the MMP-inhibitory activity [1, 28] , being instead mediated by specific structures on the cell membrane [28] (Fig. 2) . Intriguingly, however, when added together, the stimulation due to Grp94-IgG was reduced, although the expression of Akt remained still higher than the control. This result did not fit the picture of morphological alterations that even worsened when CTT was added to Grp94-IgG (Fig. 1) . Because Akt pathway plays a pivotal role in mediating angiogenic effects [19, 25] chaperone of a lot of intracellular proteins [29] [30] [31] , among which are those recruited in the crucial process of cell proliferation and differentiation [30] [31] [32] [33] , including also MMPs [1] . (Fig. 4) . However, whereas in the presence of both Grp94-IgG and CTT alone, HSP90 was almost entirely confined to cell membrane in podosomes (Fig.  3) [8, [34] [35] [36] , and shedding of MMP-9 is responsible for proteolytic activity functional to paracrine diffusion of morphogenic alterations during angiogenesis [8, 34] . Although we were unable to measure MMP-9 expression in cell lysates-MMP-9 is hardly detected as protein in HUVECs [12] -the experiments of gel zimography clearly demonstrated that MMP-9 is intensely secreted in its inactive form in the presence of Grp94-IgG and CTT, and that association further increased the MMP-9 secretion (Fig. 5) . This finding, together with the observation that also HSP90 underwent similar intense secretion, mostly when CTT was added to Grp94-IgG (Fig. 4) [37, 38] . This mechanism is exploited for blocking overexpression of oncoproteins in cancer cells that require HSP90 for establishing their malignant phenotype, and purine-scaffold inhibitors of HSP90 are emerging as promising anti-tumour agents in clinical practice [39] . We observed that PU-H71 reduced in a concentration-dependent manner the stimulation of cellular HSP90 and Akt by Grp94-IgG, and in addition caused a marked fall in the secretion of HSP90 (Figs 6 and 7) . This last effect was also displayed by PU-H71 alone, a result that suggested a mechanism by which the structural modification that HSP90 undergoes following inhibition prevents it from reaching the membrane and being secreted. This mechanism should also be supported by the observation that, in parallel with inhibition of HSP90 secretion, PU-H71 caused a fall in the MMP-9 secretion (Fig. 8) (Fig. 8) . Finally, both the steric hindrance of the complex and the fact that its effects on HUVECs are mediated by a cell-surface receptor activation [11] favour the extracellular localization of Grp94-IgG rather than its internalization, being thus Grp94 also spatially prevented from taking contact with the inhibitor.
In [40] . Although the mechanisms underlying these effects of CTT on HUVECs deserve further investigation, our present results may nevertheless offer a molecular basis for explaining the disappointing effects observed with MMP inhibitors [2, 5, 28, 41] and that drastically hampered the use of MMP inhibitors, including CTT, as effective anti-angiogenic and anti-tumour agents [41] .
